バイオプロセス容器の市場規模、シェア、成長分析：タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

バイオプロセス容器市場規模は2023年に46億3,000万米ドルとなり、予測期間（2025～2032年）のCAGRは25.2%で、2024年の58億米ドルから2032年には350億米ドルに成長する見通しです。

世界のバイオプロセス容器市場は、個別化医療に対する需要の高まりと容器技術の進歩により、大きな成長が見込まれています。バイオテクノロジーの研究開発への投資が増加するにつれて、バイオプロセス・コンテナ・プロバイダーのビジネスチャンスは拡大しています。ゲノムおよびプロテオミクスにおけるバイオプロセス容器の応用拡大とともに、マイクロアレイの革新が新たなビジネスチャンスを生み出すと期待されています。さらに、デバイスの小型化動向、マイクロ流体工学の進歩、オルガノイドの需要が市場開拓の原動力となります。慢性疾患の有病率の上昇と早期診断の必要性は、市場の成長をさらに高めると思われます。しかし、設計の複雑さ、開発コストの高さ、利点の認知度の低さといった障害は、この分野の進展を妨げる課題として残っています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

バイオプロセス容器市場規模：タイプ別

• 市場概要
• 2Dバイオプロセス容器
• 3Dバイオプロセス容器
• その他の容器および付属品

バイオプロセス容器市場規模：用途別

• 市場概要
• 上流プロセス
• 下流プロセス
• プロセス開発

バイオプロセス容器市場規模：エンドユーザー別

• 市場概要
• 製薬・バイオ医薬品企業
• CROとCMO
• 学術調査機関

バイオプロセス容器市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Sartorius AG（Germany）
• Thermo Fisher Scientific Inc.（US）
• Danaher Corporation（US）
• Merck KGaA（Germany）
• Corning Incorporated（US）
• Saint-Gobain（France）
• Avantor, Inc.（US）
• Parker Hannifin Corporation（US）
• Entegris, Inc.（US）
• Meissner Filtration Products, Inc.（US）
• Lonza AG（Switzerland）
• Flexbiosys Inc.（US）
• ABEC, Inc.（US）
• Cellexus（UK）
• GE Healthcare（US）
• Rim Bio（US）
• ALLpaQ Packaging Group（UK）
• Fluids Control（Argentina）
• Cole-Parmer Instrument Company, LLC（US）
• Cytiva（US）

結論と提言

Bioprocess Containers Market size was valued at USD 4.63 billion in 2023 and is poised to grow from USD 5.8 billion in 2024 to USD 35.0 billion by 2032, growing at a CAGR of 25.2% during the forecast period (2025-2032).

The global bioprocess containers market is poised for significant growth, driven by the increasing demand for personalized medicine and advancements in container technologies. As investments in biotechnology R&D rise, opportunities for bioprocess container providers are expanding. Innovations in microarrays, alongside the growing application of bioprocess containers in genomics and proteomics, are expected to create new business avenues. Additionally, trends toward device miniaturization, advancements in microfluidics, and the demand for organoids are set to fuel market development. The rising prevalence of chronic diseases and the need for early diagnostics will further enhance market growth. However, obstacles such as design complexity, high development costs, and limited awareness of benefits remain challenges that could hinder progress in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioprocess Containers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioprocess Containers Market Segments Analysis

Global Bioprocess Containers Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into 2D bioprocess containers, 3D bioprocess containers and Other containers and accessories. Based on Application, the market is segmented into Upstream Processes, Downstream Processes and Process Development. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs and Academic & Research Institutes.. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioprocess Containers Market

The bioprocess containers market is being propelled by a surge in global investments aimed at developing innovative biopharmaceutical products and biologics. As the demand for monoclonal antibodies, vaccines, and other biologics continues to rise, there is an increasing need for efficient bioprocess containers to facilitate their production, storage, and transportation. This trend not only underscores the importance of bioprocess containers in the biopharmaceutical industry but also highlights the significant growth opportunities within this market. The ongoing expansion and evolution of biopharmaceuticals are essential drivers for the adoption of advanced containment solutions in the industry.

Restraints in the Bioprocess Containers Market

The bioprocess containers market faces a significant restraint due to environmental concerns related to plastic waste. As sustainability becomes an increasingly important focus globally, the disposal of bioprocess containers, which often utilize non-biodegradable plastics, poses a challenge. The prevalent use of single-use bioprocess containers further exacerbates the issue, leading to a growing awareness of the environmental impact associated with their disposal. This situation may hinder the broader acceptance and adoption of bioprocess containers, as stakeholders in various industries strive to adopt more sustainable practices and materials in response to mounting ecological pressures.

Market Trends of the Bioprocess Containers Market

The bioprocess containers market is witnessing a notable trend towards customization, driven by the diverse and evolving demands of biopharmaceutical companies globally. With a surge in biologics production and the need for tailored solutions, manufacturers that offer bespoke bioprocess containers are poised for significant growth. This customization trend not only meets the specific requirements of various biologics but also enhances operational efficiency and regulatory compliance for end-users. As the industry increasingly shifts towards personalized medicine and innovative therapies, the demand for specialized, adaptable bioprocess containers is expected to thrive, positioning customization as a key market driver in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Bioprocess Containers Market Size by Type & CAGR (2025-2032)

• Market Overview
• 2D bioprocess containers
• 3D bioprocess containers
• Other containers and accessories

Global Bioprocess Containers Market Size by Application & CAGR (2025-2032)

• Market Overview
• Upstream Processes
• Downstream Processes
• Process Development

Global Bioprocess Containers Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biopharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes.

Global Bioprocess Containers Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saint-Gobain (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Entegris, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meissner Filtration Products, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flexbiosys Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABEC, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellexus (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rim Bio (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALLpaQ Packaging Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluids Control (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cole-Parmer Instrument Company, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations